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Abstract
Dengue virus (DENV) has caused recent outbreaks in coastal cities of Kenya, but the epide-
miological situation in other areas of Kenya is largely unknown. We investigated the role of
DENV infection as a cause of acute febrile disease in non-epidemic settings in rural and
urban study areas in Kenya. Altogether, 560 patients were sampled in 2016–2017 in rural
Taita–Taveta County (n = 327) and urban slums of Kibera, Nairobi (n = 233). The samples
were studied for DENV IgM, IgG, NS1 antigen and flaviviral RNA. IgG seroprevalence was
found to be higher in Taita–Taveta (14%) than in Nairobi (3%). Five Taita–Taveta patients
were positive for flaviviral RNA, all identified as DENV-2, cosmopolitan genotype. Local
transmission in Taita–Taveta was suspected in a patient without travel history. The
sequence analysis suggested that DENV-2 strains circulating in coastal and southern
Kenya likely arose from a single introduction from India. The molecular clock analyses dated
the most recent ancestor to the Kenyan strains a year before the large 2013 outbreak in
Mombasa. After this, the virus has been detected in Kilifi in 2014, from our patients in Taita–
Taveta in 2016, and in an outbreak in Malindi in 2017. The results highlight that silent trans-
mission occurs between epidemics and also affects rural areas. More information is needed
to understand the local epidemiological characteristics and future risks of dengue in Kenya.
Author summary
Dengue virus (DENV) is an emerging mosquito-borne global health threat in the tropics
and subtropics. The majority of the world’s population live in areas at risk of dengue that
can cause a wide variety of symptoms from febrile illness to haemorrhagic fever. Informa-
tion of DENV in Africa is limited and fragmented. In Kenya, dengue is a recognized dis-
ease in coastal cities that have experienced recent outbreaks. We investigated the role of
DENV infection as a cause of acute febrile disease in non-epidemic settings in rural and
urban study areas in Kenya. We found DENV-2 in five febrile patients from rural Taita–
PLOS NEGLECTED TROPICAL DISEASES
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008099 March 3, 2020 1 / 17
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Masika MM, Korhonen EM, Smura T,
Uusitalo R, Vapalahti K, Mwaengo D, et al. (2020)
Detection of dengue virus type 2 of Indian origin in
acute febrile patients in rural Kenya. PLoS Negl
Trop Dis 14(3): e0008099. https://doi.org/10.1371/
journal.pntd.0008099
Editor: Joao Trindade Marques, Universidade
Federal de Minas Gerais, BRAZIL
Received: June 18, 2019
Accepted: January 29, 2020
Published: March 3, 2020
Copyright: © 2020 Masika et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files.
Funding: This work was funded by The Centre for
International Mobility (CIMO) Finland to MM, the
Paulo Foundation to EH, Academy of Finland to OV,
Helsinki University to OV, Hospital (HUSLAB;
TYH2017257), Jane and Aatos Erkko Foundation,
Finland to OV, and Finnish Cultural Foundation,
Kymenlaakso Foundation to EMK. The funders had
no role in study design, data collection and
Taveta, where no dengue has been reported before. Genetic analysis of the virus suggests
it to be most likely of Indian origin. This Indian origin DENV-2 was detected in the Mom-
basa outbreak in 2013, in Kilifi in 2014, in Taita–Taveta in 2016 (our study samples) and
again in the Malindi outbreak in 2017. The results suggest that dengue is unrecognized in
rural Kenya and more studies are needed for local risk assessment. Our findings of virus
transmission between epidemics contribute to better understanding of the epidemiologi-
cal situation and origins of DENV in Kenya.
Introduction
Family Flaviviridae, genus Flavivirus, includes important mosquito-borne human pathogens
such as the yellow fever, Zika, West Nile and dengue viruses, all found in Africa [1]. Dengue
viruses (DENV-1 to 4) have a significant impact on public health globally, but their impact in
Africa is less characterized, and the available information and sequence data are fragmented
[2, 3].
Serological data indicates the most active circulation of dengue in Kenya to occur in coastal
region but low seroprevalences have also been reported from western and northern parts of
the country [4–7].
First records of dengue in Kenya are from 1982, when there was a large outbreak caused by
DENV-2 in the coastal area involving the cities of Kilifi and Malindi. The seroprevalence in
the outbreak area was 52% after the outbreak [8]. In 2013 an outbreak caused by DENV-2
occurred in Mombasa. From this outbreak three DENV-2 isolates were obtained and
sequenced [9], followed by ten strains of cosmopolitan genotype DENV-2 obtained from
patient samples collected in 2014–2015 in Kilifi [10]. Again in 2017 an outbreak occurred in
Malindi, where ten strains of related cosmopolitan genotype DENV-2 were isolated [11] dem-
onstrating sustained DENV-2 circulation in Kenya.
The other serotypes of DENV have also been reported in Kenya, however the sequence data
is very limited or lacking leaving the involved genotypes of the detected virus strains unknown.
In 2011 an outbreak caused by DENV-3 was reported from Mandera region, north east Kenya
[12]. During 2011–2014 samples of febrile patients were studied for dengue in Nairobi, north-
ern and coastal Kenya resulting in detection of DENV-1–3, DENV-1 was reported to be the
dominating serotype [13]. DENV-1 was also reported to be the dominating serotype in febrile
children of Chuilambo and Kisumu, Western Kenya in 2014–2015, with all the four DENV
serotypes detected by using DENV typing RT-PCR [14]. The main vector of DENV Aedes (Ste-
gomyia) aegypti is known to be present in western parts and the coastal region of Kenya [15–
18]. Sylvatic cycles of DENV are known to exist in Western Africa [19]. These have not been
detected in Kenya, although sylvatic yellow fever virus is known to circulate and the environ-
mental factors would likely allow sylvatic cycles of DENV as well [20].
Detection of dengue or other flaviviral infections requires the use of specific laboratory test-
ing, as the symptoms are often unspecific. Except for malaria, diagnostic tests are usually not
available at the point of care, especially in rural areas of Kenya [21]. The aim of this study was
to determine the role of DENV infection (and potentially other flaviviruses) in acute febrile
patients in a non-outbreak situation, in urban and rural areas of Kenya. We investigated the
role of DENV infection as a cause of acute febrile disease in non-epidemic settings in rural and
urban study areas in Kenya with molecular methods. In addition, we aimed to obtain informa-
tion on the rate of past exposure to flaviviruses in these cohorts with serological methods.
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Methods
Study design
The study sample collections were carried out in Kibera slum in Nairobi city and in rural
Taita–Taveta County. Kibera slum is characterized by poor drainage, stagnant pools of water,
congested and poorly litter, semi-permanent houses and a high human population density
[22]. The rural Taita Hills area in Taita–Taveta County includes landscapes differing in alti-
tude, vegetation and climate stretching over lowland savannah, Afromontane forested high-
lands and two national parks [23]. Taita–Taveta is traversed by new railway and road
constructions and is proximal to the Kenyan coastline, which is known to have the highest
prevalence of arboviral infections in Kenya [24].
With approval from Kenyatta National Hospital-University of Nairobi Ethics and Research
Committee (permit number P707/11/2015) samples were collected from voluntary febrile
patients in six health facilities in Taita–Taveta in April to August 2016 and Kibera in February
to June 2017 (Fig 1). Adult subjects provided written informed consent, and a parent or guard-
ian of any child participant provided written informed consent on the child’s behalf. Any
patient with a temperature of 37.5˚C or higher was eligible for inclusion in the study. A total of
560 samples (sera or plasma) were collected in this study: 327 from Taita–Taveta County and
233 from Kibera slum in Nairobi. The samples were taken from the patients when they first
entered the healthcare facility and represent the acute phase of febrile illness ranging from
1–14 days since onset of fever (median = 2 days, interquartile range = 2 days) (Table 1). Socio-
demographic and clinical data were collected from all consenting patients using a question-
naire administered by a clinician. Serum samples were collected from all study participants in
Taita–Taveta (n = 327) and plasma samples from the participants in Kibera (n = 233). The
samples were initially stored at -20˚C in the Taita—Taveta area (for up to three weeks before
getting them to Nairobi) prior to storage at -80˚C.
Antibody and antigen testing
Initial IgG and IgM antibody screening was done using an in-house immunofluorescence
assay (IFA) with DENV-3 (H87) antigen [25–27]. The samples were diluted 1:20 in phosphate-
buffered saline for testing in IFA. Samples that were found to be positive for IgG at 1:20 dilu-
tion were further titrated until the last positive dilution was reached. The IgG-positive samples
were treated with GullSORB IgG inactivation reagent (Meridian Bioscience, Cincinnati, USA)
prior to IgM IFA testing. Known DENV IgG and IgM positive samples were used as positive
controls in the IFA tests. For the samples reactive by IgM IFA, a commercial dengue IgM
enzyme immunoassay (EIA) was performed according to the manufacturer’s instructions
(Capture DXSelect, Focus Diagnostics, Cypress, USA). Samples that were found to be positive
in DENV IgM EIA, IgG IFA or viral RNA screening were additionally tested for dengue NS1
antigen using Platelia Dengue NS1 Ag test (BIORAD). If there was enough sample volume left,
DENV IgG IFA positive samples were further tested for anti-Zika (ZIKV) virus IgG using a
commercial ELISA test (Euroimmun, Luebeck, Germany), and samples positive for DENV
IgM IFA were tested for anti-ZIKV IgM using an ELISA test (Zika IgA/M, Euroimmun, Lue-
beck, Germany) according to the manufacturer’s instructions (Fig 2A).
Nucleic acid extraction and flaviviral RNA detection
Nucleic acids were extracted from 200μl of serum or plasma sample using a MagNa Pure LC
instrument and MagNa Pure LC Total Nucleic Acid Kit (Roche, Basel, Switzerland) with an
elution volume of 50μl. A pan-flavivirus RNA screening, targeting the NS5 gene, was
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performed using a real-time SYBR green one-step RT-PCR assay followed by a semi-nested
amplification and agarose gel electrophoresis as described in detail by Moureau et al. [28, 29].
A total of 5μl of the nucleic acid extract was used as a starting material according to the Mour-
eau et al. protocol, with the modification of using DreamTaq DNA polymerase (Thermo
Fisher Scientific) in the semi-nested amplification step. Tick-borne encephalitis virus strain
Kumlinge A52 (a non-endemic flavivirus to Kenya) RNA was used as a positive control in the
pan-flavivirus RNA screening.
Additional DENV-2 envelope (E) gene region nested RT-PCR was done for selected sam-
ples. The RT step was done using Maxima reverse transcriptase, random hexamers and Ribo-
Lock RNase inhibitor following the manufacturer’s instructions. The PCR steps were done
using DreamTaq DNA polymerase (Thermo Fisher Scientific, Waltham, USA) using DENV-2
E-gene specific primers: first round forward primer 50-CATGGATGTCATCAGAAGGG-30,
first round reverse primer 50-CCTTTRATGTCTCCT GTCAT-30, second round forward
Fig 1. Maps of study areas in Kenya. The smaller map shows the locations of the study sites in Nairobi and the Taita Hills, as well as the dengue endemic coastal cities
with reported dengue virus (DENV) -2 outbreaks (Mombasa 2013 and Malindi 2017) [11, 15]) and the town of Kilifi where DENV-2 was detected in febrile patients in
2014 [10]. The larger map shows more detailed sample collection locations in Voi, Wundanyi and Mwatate in Taita–Taveta County. The towns are designated with a
square and villages with a circle. The hospitals where the samples were collected are designated with white circles and represent A) Mwatate Sub-County Hospital, B)
Wundanyi Sub-County Hospital and C) Moi County Referral Hospital, Voi.
https://doi.org/10.1371/journal.pntd.0008099.g001
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primer 50-GGRTYYTGAGACATCCAGG-30 and second round reverse primer 50-TCTGRT
GTTATYTGTTTCCAC-30.
The first and second round PCRs were carried out in 50μl reaction volumes using 2μl of
cDNA in the first round PCR. A total of 2μl of the first round PCR product was used as a tem-
plate in the second round PCR. The thermal cycling conditions (for both rounds) included ini-
tial denaturation at 95˚C for 3min followed by 35 times a cycle at 94˚C for 40s, 50˚C for 50s,
and 72˚C for 1.5min.
Virus isolation
Virus isolation was attempted from DENV-2 RNA positive samples where a suitable amount
of material was available (n = 3) in Vero E6 (ATCC CRL-1586) and C6/36 Aedes albopictus
Table 1. Demography, exposures and symptoms in the total study population (n = 560).
Taita- Taveta Nairobi Other�
Variable n % n % n %
No. of subjects 322 57.5 230 41.1 8 1.4
‘dengue marker positive’ 47 14.6 8 3.5
<30 �30 Missing
n % n % n %
Age 365 65.18 184 32.86 11 1.96
Female Male Missing
n % n % n %
Gender 287 51.25 263 46.96 10 1.79
Patient history Yes No Missing
n % n % n %
Travel history 142 25.4 413 73.8 5 0.9
HIV positive 77 13.8 483 86.3 0 0.0
Malaria positive 59 10.5 501 89.5 0 0.0
Contact with goats 160 28.6 400 71.4 0 0.0
Contact with cattle 123 22.0 437 78.0 0 0.0
Contact with sheep 38 6.8 522 93.2 0 0.0
Contact with swine 1 0.2 559 99.8 0 0.0
Contact with chicken 236 42.1 324 57.9 0 0.0
Contact with dogs 95 17.0 465 83.0 0 0.0
Contact with cats 151 27.0 409 73.0 0 0.0
Contact with rodents 345 61.6 215 38.4 0 0.0
Contact with bats 100 17.9 460 82.1 0 0.0
Rash 34 6.1 526 93.9 0 0.0
Joint pain 209 37.3 351 62.7 0 0.0
Myalgia 190 33.9 370 66.1 0 0.0
Vomiting 122 21.8 438 78.2 0 0.0
Diarrhoea 77 13.8 483 86.3 0 0.0
Bleeding tendency 2 0.4 558 99.6 0 0.0
Headache 162 28.9 398 71.1 0 0.0
Sore throat 39 7.0 521 93.0 0 0.0
Cough 141 25.2 419 74.8 0 0.0
Mean Std
Temperature 38.61 0.63
�Place of residence not known.
https://doi.org/10.1371/journal.pntd.0008099.t001
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cells (ATCC CRL-1660) as described previously [30]. In brief 50μl of sera was inoculated to
cells grown in 25cm2 culture bottles.
Fig 2. Diagnostic assays and results: a) workflow and results for flaviviral diagnostic tests; b) dengue serological assays and RT-PCR results.
https://doi.org/10.1371/journal.pntd.0008099.g002
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Sequencing
The RT-PCR products of pan-flavivirus RNA screening (~150 bp) and DENV-2 E-gene
RT-PCR (~1500 bp) were Sanger sequenced (DNA sequencing and genomics laboratory, Insti-
tute of Biotechnology, University of Helsinki). For obtaining complete genome data, next gen-
eration sequencing (NGS) was attempted from RNA extracted from patient samples or virus
isolation samples using Illumina MiSeq (Illumina, San Diego, USA). The samples were pre-
pared using a protocol modified from Conceicao-Neto et al. [31]. Briefly, the samples were fil-
tered (0.4 μm filters), nuclease digested with benzonase (Millipore, Burlington, USA) and
micrococcal nuclease (New England Biolabs, Ispwich, USA), and finally precipitated with
polyethyl glycol (Abcam, PEG virus precipitation kit). Nucleic acid extraction was conducted
using a QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany), followed by reverse tran-
scription and amplification using a WTA2 Whole Transcriptome Amplification Kit (Sigma
Aldrich, Saint Louis, USA). The amplified DNA was purified using a GeneJet PCR Purification
Kit (Life Technologies, Carlsbad, USA) and libraries prepared using a Nextera XT kit (Illu-
mina, San Diego, USA) according to the manufacturer’s instructions. The library fragment
size was estimated using agarose gel electrophoresis and the concentration measured using a
Qubit Broad-Range dsDNA Assay Kit (Life Technologies, Carlsbad, USA) and NEBNext
Library Quant kit (New England BioLabs). The samples were sequenced using a MiSeq V2
reagent kit with 150 bp reads.
Sequence analysis
The initial virus species designation for the sequences obtained from screening RT-PCR prod-
uct by Sanger sequencing was conducted using a basic local alignment search tool (BLAST).
Raw NGS sequence reads were trimmed and low quality (quality score <30) and short (<50
nt) sequences removed using Trimmomatic [32]. The trimmed sequences were de-novo assem-
bled using a MIRA assembler (version 4.9.5. http://mira-assembler.sourceforge.net) [33] fol-
lowed by reassembly against the de-novo assembled consensus sequences using the
BWA-MEM algorithm implemented in SAMTools version 1 [34, 35]. The mean coverages
were: 6710 (range: 424–15 298) for strain 222_Voi_Kenya; 1679 (range 410–5397) for strain
c96_Wundanyi_Kenya and 51 (range 8–163) for strain 85A_Wundanyi_Kenya.
Complete coding sequences of the DENV-2 cosmopolitan genotype were retrieved from
the GenBank (accessed in 1 March 2019) for phylogenetic analysis. Representative strains of
the other DENV-2 genotypes (American, Asian American, Asian I, Asian II and sylvatic) were
also included in the initial analysis. The initial analysis suggested that the Kenyan DENV-2
strains form a distinct cluster together with strains of Indian origin. These strains were selected
for a more detailed analysis. Another data set was constructed of the E-gene that contained all
available E sequences that clustered together with the Kenyan/Indian subcluster identified on
the basis of initial complete coding sequence analysis.
The sequences were aligned using MUSCLE [36] and the substitution model was estimated
using bModelTest [37] implemented in BEAST2.5 software [38]. The phylogenetic trees were
constructed using the Bayesian Monte Carlo Markov Chain (MCMC) method implemented in
BEAST version 1.8.0 [39] using the TN93 model of substitution with 4-category gamma-dis-
tributed variation among sites and a proportion of invariant sites. Three molecular clock mod-
els (strict, log-normal relaxed and exponential) and three demographic models (constant,
exponential and Bayesian skyline) were compared by estimating marginal likelihoods by step-
ping stone and path sampling methods [40, 41]. Bayes factors (BFs) were calculated for each
pair of models. Both stepping stone and path sampling methods supported a log-normal
relaxed clock and an exponential growth demographic model over the other models (BF >60).
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The analyses were run for 50 million states and sampled every 5000 steps. Posterior probabili-
ties were calculated with a burn-in of 10% and checked for convergence using Tracer version
1.7 [39]. The analyses were carried out on the CSC server (IT Center for Science, Espoo,
Finland).
Statistical tests of questionnaire data
Statistical analyses combining diagnostic test results and questionnaire data were performed
for 499 patients out of the total 560 patients (61 patients were excluded because positive IgM
IFA could not be confirmed by IgM EIA or due to incomplete questionnaire data). We used
SAS 9.4 (SAS Institute, Cary, NC, USA) in the analyses, which included Fisher’s exact test and
logistic regression analyses with the level of significance set at 95% (p-value <0.05). Multivari-
able logistic regression analysis was used to find the most significant risk factors and to control
the effects of confounding variables. Based on diagnostic assay results, patients were divided
into groups of ‘DENV marker positive’ (positive in any test) and ‘DENV marker negative’
(negative in all tests).
This status (DENV marker positive or negative) served as a response variable, and age, gen-
der and county were defined as confounding variables. Continuous age was reduced to two
categories with age<30, or�30. First, potential risk variables were individually examined in
the model with confounding variables. Then, the variables that proved to be significant in
these models were tested in different combinations in a model with confounding variables to
find the best multivariable model with the most significant risk factors. Interactions and multi-
collinearity between all variables in the models were tested. The phi coefficient was utilized in
measuring multicollinearity and a value of>0.5 was set as a limit for strong multicollinearity
[42]. The best model was selected according to the Pearson goodness-of-fit, AIC and AUC val-
ues of the model.
Results
Patient characteristics and associations with DENV marker positivity
A total of 560 samples (sera or plasma) were collected in this study; 327 from Taita–Taveta
County and 233 from Kibera slum in Nairobi (Table 1). The samples were taken from the
patients when they first entered the health care facility, and represent the acute phase of febrile
illness ranging from 1–14 days since onset of fever (median = 2 days, interquartile range = 2
days) (Table 1). The patients included 322 residents of Taita–Taveta County and 230 of Kibera,
Nairobi. The place of residence was not known for eight patients. A quarter of all patients had
travelled outside their county of residence within the previous month. No trips abroad were
reported by any of the patients. In addition, patients also reported joint pain (37%), myalgia
(34%), headache (30%), cough (25%), vomiting (22%), diarrhoea (14%), sore throat (7%) and
rash (6%). Information of HIV positivity was available for 14% and malaria test was positive in
11% of all the study patients (Table 1).
According to Fisher’s exact test (S1 Table), DENV marker positivity was significantly more
common in Taita-Taveta compared with Nairobi, in age group�30 years compared with age
group <30 years and among females compared with males. In addition, contact with goats,
chickens or bats was more common among ‘DENV marker positive’ than ‘DENV marker neg-
ative’ patients. When studied separately in Taita–Taveta patients, similar significant differ-
ences were found in age, gender and travel history (S1 Table). Further statistical testing
included examining the effects of risk factors in multivariable models which included con-
founding factors. In the county of Taita-Taveta only, the best model included the variables age,
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gender and travel history. In the whole study group of Taita-Taveta and Nairobi together, also
significant interaction between the variables chicken and age was found (Table 2).
No significant multicollinearity was found between the variables in the models. Both in the
whole study group and Taita-Taveta solely, the confounding factors turned out to be risk fac-
tors as well. The low number of ‘DENV marker positive’ patients (n = 8) did not allow a more
detailed analysis of the patients sampled in Nairobi.
Diagnostic assay results
The IgG seroprevalences of patients sampled in Taita–Taveta was higher (14%) than in
patients sampled in Nairobi (3%). Altogether, 9.1% (51/560) of samples were found to be posi-
tive in DENV IgG IFA and 3.9% (3/76) of IgM IFA positive samples were also positive by com-
mercial IgM EIA (Fig 2B). The IgG IFA titres ranged from 10 to 2560. 12 samples had low
titres (10–20), 31 samples had intermediate titers (40–160) and 7 samples had high titers (640–
2560). For one sample, the titre could not be determined after the initial screening dilution
due to a lack of sample volume. In ZIKV antibody tests, 1/51 and 1/57 were found to be posi-
tive for ZIKV IgG and IgM, respectively.
Acute DENV infection was documented by molecular methods in five patients who were
found to be positive in pan-flavivirus RNA screening (0.9%) and further confirmed by
sequencing. All these patients were sampled in Taita–Taveta County (Table 3). Four of the five
PCR-positive samples were collected in May 2016 and one in June 2016. The DENV NS1 anti-
gen assay was positive in three of the viral RNA positive patients. Virus isolation was attempted
for three DENV-2 RNA positive samples, for which sufficient amounts of sample were avail-
able. The virus was successfully isolated from two samples in C6/36 cells (Table 3, Fig 2A)
Both of the strains showed cytopathic effects in infected cells (as rounding and appearance of
loose cells) after subcultures on days 20 and 24.
In addition to these five confirmed dengue patients, acute flaviviral infection was suspected
in three additional patients (0.5%) with a positive IgM EIA (Capture DXSelect, Focus Diagnos-
tics) result. The patients positive for DENV IgG only (6.4%) were considered to have old flavi-
viral immunity (Fig 2B).
Table 2. Best logistic regression models for DENV in the whole study group (Taita Taveta and Nairobi combined) and in Taita Taveta solely.
Model fit statistics
Variables AIC AUC Pearson p OR Lower 95%CI Higher 95%CI
Whole study group Age_group 287.52 0.80 0.99 < .0001 . . .
Gender: female vs male 0.02 2.32 1.19 4.71
County�TravelHistory 0.23 5.2 2.24 11.94 1)
1.71 0.35 8.30 2)
Age_group�Chicken 0.01 0.5 0.22 1.19 3)
2.74 0.95 7.95 4)
Taita Taveta Age_group: > = 30 vs <30 229.85 0.74 0.91 0.00 3.46 1.67 7.60
Gender: female vs male 0.02 2.51 1.21 5.51
Travelhistory < .0001 5.82 2.53 13.69
1) Travel history at County = Taita Taveta
2) Travel history at County = Nairobi
3) Chicken�Age = > 30 yrs
4) Chicken�Age < 30 yrs
Indicators of model goodness: AIC, AUC and Pearson Goodness-of-Fit.
https://doi.org/10.1371/journal.pntd.0008099.t002
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Sequencing and phylogenetic analysis
Using Sanger sequencing, the pan-flavivirus screening RT-PCR products (n = 5, ~ 150bp)
were identified as DENV-2 with high identity matches in the BLAST search. A total of three
complete DENV-2 coding sequences and one E-gene sequence were obtained in this study
(Table 3). The attempt to obtain longer viral sequences for analysis were not successful in one
sample (number 76). This sequence was 99–100% identical to the other sequences obtained in
this study.
Phylogenetic analysis based on all the available DENV-2 cosmopolitan genotype complete
coding sequences (n = 30) suggested that the Kenyan strains form a single monophyletic clus-
ter, and the strain T90_S83 from New Delhi, India (year 2014) formed an out-group for all the
recent Kenyan DENV-2 strains. These strains clustered further with strain RGCB880 from
Kerala, India (year 2010) (Fig 3A).
Since there are more E-genes than complete genomes in the GenBank, a distinct data set
was constructed from the closest BLAST search matches to the Kenyan DENV-2 E-genes. The
E-gene sequence analysis (1485 bp) included 63 sequences from years 2009–2017 (Fig 3B).
Table 3. Characteristics of dengue virus RNA positive patients.
Sample
ID
Collection
place and date
Travel
history
Symptoms
(days)
Patient
age/
sex�
Sampling
day��
IgG
(IFA)
titre
IgM
(IFA)
IgM EIA
dengue
Pan- flavi
virus
RT-PCR
DENV
NS1 Ag
Virus
isolation
Sequence
confirmation
76 Wundanyi
16-May-2016
Nairobi Fever (2) 3 F 2 <20 <20 Neg Pos ND ND DENV-2, partial
cds
NS5 132 bp
(Sanger) ���
85A Wundanyi
10-May-2016
Mombasa Fever (2)
Joint pain
(2)
Myalgia (2)
16 F 2 640 20 Neg Pos Pos Pos DENV-2,
complete cds
(NGS from virus
isolate)
GenBank
accession:
MK473385
c96 Wundanyi
4-May-2016
Mombasa Fever (2)
Joint pain
(2)
Myalgia (2)
Headache
(2)
19 F 2 <20 <20 Neg Pos Pos Pos DENV-2
complete cds
(NGS from virus
isolate)
GenBank
accession:
MK473384
509 Mwatate
24-Jun-2016
No recent
travelling
Fever (3)
Myalgia (3)
Rash (3)
46 M 3 <20 <20 Neg Pos Neg Neg DENV-2,
partial cds, E-
gene,
1485 bp Sanger
GenBank
accession:
MK473383
222 Voi
4-May-2016
Mombasa Fever (2) 17 M 2 40 <20 Neg Pos Pos ND DENV-2,
complete cds.
direct NGS from
sample,
GenBank
accession:
MK473386
� M = male, F = female
�� sampling day since onset of fever ��� available from the authors upon request; DENV-2 = Dengue virus type 2
https://doi.org/10.1371/journal.pntd.0008099.t003
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Consistently with the complete coding sequence analysis, all the Kenyan sequences formed a
monophyletic group most closely related to sequences from New Delhi, India, in the year 2014
[43] (tMRCA: 2012 [95% HPD 2011–2012]). In addition to the strains mentioned above, the
sister group included sequences originating from India and Singapore. Interestingly, the strain
from a traveller patient returning from a trip to Djibouti and Ethiopia in 2016 was found to be
closely associated with the New Delhi strains in the E-gene analysis. The recent (years 2016–
2017) Kenyan strains formed a monophyletic cluster that was further divided into four highly
supported subclusters. Strain c96 from Wundanyi in 2016 clustered together with a strain iso-
lated from a patient travelling from Kenya to Taiwan in March 2016, whereas the strains 509
from Mwatate, 85A from Wundanyi and 222 from Voi in 2016 clustered together with three
strains from Malindi in 2017.
The molecular clock analysis dated the most recent common ancestor (MRCA) for the Ken-
yan strains in year 2012 (95% HPD 2012–2013); a year prior to the 2013 epidemic in Mom-
basa. For the sequences sampled in this study and those sequenced from Malindi, the time to
the most recent common (tMRCA) was 2014 (95% HPD 2014–2015).
Discussion
Neither of our study areas had documented previous DENV outbreaks. Dengue outbreaks
have occurred previously mainly in the coastal area of Kenya, and although some cases have
been detected in Nairobi, it is not considered dengue endemic area with sustained transmis-
sion. The 3% seroprevalence of IgG against flaviviruses in Kiberan febrile patients was in line
with the previous general population survey of Nairobi, where IgG seroprevalence was 3.5% in
2007 [24]. No signs of acute flavivirus/dengue infections were detected in any of the Kiberan
patients.
No previous information was available for rural Taita–Taveta County regarding flavivirus
seroprevalence or DENV transmission. The flavivirus IgG seroprevalence in Taita–Taveta was
found to be 14%, which is considerably higher than in Nairobi but yet notably lower than in
coastal region (34–67%) [4, 5]. The location of Taita-Taveta near to the dengue endemic
coastal counties is likely a factor contributing to the higher seroprevalence [4, 24, 44]. The
result may also be influenced by patient age, as the adult patients sampled in Taita–Taveta
were probably more likely to be exposed to DENV or other flaviviruses during their life, than
the younger patients sampled in Nairobi. The seroprevalence data obtained from this study
cohort of febrile patients may not represent the general population in the region, and further
studies with comparable study cohorts, such as general population would be needed for evalu-
ating the regional exposure to flaviviruses in different regions of Kenya.
The lack of convalescent samples limited the further testing and interpretation of the sero-
logical results obtained from single time point samples. The IgG positivity alone without other
positive test results was considered old immunity, however this may be due to other past flavi-
virus exposure than DENV. The serological cross-reactions are common between different fla-
viviruses, and Kenya is known to be endemic, in addition to DENV, to West Nile virus, yellow
fever virus (YFV) and Wesselsbron virus [5]. YFV vaccination status of the patients was not
known, but no routine vaccinations were ongoing in the study areas. As the study was targeted
Fig 3. Phylogenetic trees of dengue virus 2 a) Complete open reading frame sequences and b) envelope gene sequences. In a) the
nodes of respective tMRCAs are shown with arrows. For both a) and b), maximum clade credibility tree of dengue virus 2 are
presented, including strains that had>98% sequence identity in the BLAST search. Trees were constructed using the Bayesian
MCMC method with the TN93 model of substitution with a 4-category gamma-distributed variation among sites and a proportion
of invariable sites, log-normal relaxed clock model and exponential growth demographic model. Posterior probabilities are shown
for each node.
https://doi.org/10.1371/journal.pntd.0008099.g003
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at acute phase febrile patients and the sample volumes were limited, the typing of IgG antibody
specificities via neutralization assays was not attempted. Notably, only two DENV seropositive
patients were found to be positive also for ZIKV NS1 specific antibodies: one for IgG and one
for IgM. Both of these patients reported recent travel to western Kenya where ZIKV neutraliz-
ing antibodies have been previously detected [7]. The reason for the high number of patients
positive for DENV IgM IFA but negative in all other tests (n = 59) remains unclear and raises
questions of the reliability and specificity of this in-house test. However, taking into account
the timing of sampling and dengue marker appearance in dengue patients [45], the used diag-
nostic methods should have detected acute DENV or other flaviviral infections.
The statistical analyses of questionnaire data was used to investigate associations of demo-
graphic data to diagnostic findings. The multivariable modelling of the available data obtained
suggested that age (>30 years), female gender and travel (especially among the Taita–Taveta
patient group) were significant risks factors for being positive in the flavivirus diagnostic tests.
Notably, the travel history of the patients in this study included only domestic travel. Intrigu-
ingly, among younger patients, an association was found between contact with chicken and
diagnostic test positivity. Whether this translates to environmental characteristics such as the
presence of water containers that could influence vector breeding and abundance remains to
be elucidated. However, this effect was not detected in patients over 30 years of age.
DENV-2 RNA was detected in five patients sampled in Taita–Taveta. The patients’ travel
history implied that most of these infections could have originated in Mombasa (3/5) or Nai-
robi (1/5). One of the DENV-2 RNA positive patients was sampled in Mwatate and had not
travelled in the preceding month. This would be compatible with local transmission of DENV-
2 in the region. Interestingly, Aedes (Stegomyia) aegypti, which has been mainly associated
with urban settlements in Kenya [16, 18], was repeatedly observed in some villages of Taita–
Taveta County [46]. Our ongoing studies of the local mosquitoes may provide further evidence
of the occurrence of the local transmission of DENV in Taita–Taveta.
The sequence analysis was restricted due to the limited amount of DENV sequence data
obtained in this study, and available in public databases from previous studies in Kenya and
the neighbouring countries. In this study, a single DENV serotype (DENV-2) and genotype
(Cosmopolitan) was detected. Our sequence data from Taita–Taveta, located inland approxi-
mately 150 kilometres from the coast, is from the year 2016 and thus timed between the two
large dengue outbreaks of the coastal cities of Mombasa in 2013 and Malindi in 2017. The find-
ings are in line with previous work, which used complete genomic data and concluded that the
2017 Malindi outbreak strains were clonally derived and closely related to strains from India
[11]. Our analysis further estimated the timing of the introduction of this lineage to Kenya a
year before the 2013 Mombasa outbreak. The currently available data suggest, that after the
2013 Mombasa outbreak the virus spread towards the northeast along the coast. The virus was
detected from febrile patients in Kilifi in 2014 [10] and later caused the Malindi 2017 outbreak
[11] (Fig 1). In our analysis, the sister group to all the Kenyan cosmopolitan DENV-2 strains
included Indian strains and interestingly also a strain originating from Djibouti or Ethiopia in
2016 from a traveller patient. This suggests that dispersal of DENV-2 between Africa and India
has occurred more than once. Globalization has probably facilitated the introduction of the
Indian DENV to Kenya, as Kenya along with other African countries interacts actively with
India for trade and travel [47], and India is hyperendemic for DENV [48].
To conclude, we detected unnoticed DENV-2 transmission outside epidemics and previ-
ously known endemic regions in rural Kenya. Dengue was not a common cause of acute febrile
disease in the study area of rural Taita-Taveta. However, as asymptomatic people were not
included in this study, the true level of infections remains to be determined. The subclinical
infections enable the silent transmission and may constitute the majority of the infections in
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an non-outbreak situation [49, 50]. The unrecognition of dengue due to lack of diagnostic test-
ing is likely to lead to underestimates of its impact to the public health. Further studies would
be needed for assessing the disease burden and for understanding the dynamics, maintenance
and spread of dengue from the endemic coastal Kenya area to new areas. The monitoring of
the population exposure would be needed in areas where the vector Aedes (Stegomyia) aegypti
is present for risk assessment, preparedness and planning of possible prevention measures.
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